The Promoted Inhibition of Complement Aetivation by CR1 / MCP Hybrid Molecule.
- Author:
Seok Yong KIM
- Publication Type:Original Article
- MeSH:
Animals;
Antibodies;
Antigens, CD46;
Catalytic Domain;
Complement System Proteins*;
Consensus;
Humans;
Mice;
Receptors, Complement;
Tissue Donors;
Transplantation, Heterologous
- From:Journal of the Korean Society for Microbiology
1997;32(6):645-652
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hyperacute rejection (HAR) is the major obstacle to xenotransplantation. In HAR complement (C') cascade is activated following the binding of xenoreactive antibodies to the donor tissue. Complement receptor type 1 (CR1), the most efficient protein in inhibiting activated C's, was modified with membrane cofactor protein (MCP) to make a more efficient C'-inhibiting hybrid molecule. Modification was done by swapping the four active site short consensus repeats (SCRs) of MCP for the SCRs 8-11 of CR1. The hybrid molecule (CR1/MCP) was expressed on the surface of mouse L cells. When the complement inhibitory activity of the CR1/MCP protein was compared with that of the wild CR1 (wCR 1) protein, CR1/MCP's inhibitory activity was weaker than wCR1's. CR1/MCP protein's L cell protecting activity from complement's attack was more prominent in adherent state than in suspension state. From these results it was suggested that the conformational direction of MCP's inhibitory action on C' is different from that of CR1 and most of the MCP expression seems to be confined to the apical side but not to the basal side of the L cell in adherent state. The wCR1's expression seems to be present on all sides of the L cell. Finally, the inverted direction of SCRS-11 of CR1 or variable length of the serine-threoninrich structure of MCP could be tried to make other CR1/MCP variants with more powerful C' inhibitory activities.
